| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 18 | 2021 | 450 | 3.930 |
Why?
|
| Pulmonary Artery | 11 | 2021 | 323 | 3.310 |
Why?
|
| Norwood Procedures | 6 | 2019 | 61 | 3.270 |
Why?
|
| Hypoplastic Left Heart Syndrome | 7 | 2019 | 138 | 3.200 |
Why?
|
| Heart Transplantation | 15 | 2023 | 328 | 3.090 |
Why?
|
| Heart-Assist Devices | 15 | 2022 | 221 | 3.030 |
Why?
|
| Fontan Procedure | 8 | 2022 | 129 | 2.430 |
Why?
|
| Heart Defects, Congenital | 15 | 2021 | 596 | 2.390 |
Why?
|
| Arterial Switch Operation | 3 | 2022 | 10 | 1.830 |
Why?
|
| Transposition of Great Vessels | 3 | 2022 | 51 | 1.770 |
Why?
|
| Mitral Valve Insufficiency | 5 | 2017 | 99 | 1.730 |
Why?
|
| Vascular Surgical Procedures | 5 | 2020 | 168 | 1.610 |
Why?
|
| Heart Septal Defects, Ventricular | 3 | 2021 | 59 | 1.470 |
Why?
|
| Coronary Vessels | 3 | 2019 | 313 | 1.450 |
Why?
|
| Infant | 22 | 2023 | 2891 | 1.420 |
Why?
|
| Postoperative Complications | 13 | 2022 | 1615 | 1.390 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2017 | 277 | 1.310 |
Why?
|
| Aortic Coarctation | 3 | 2019 | 37 | 1.290 |
Why?
|
| Heart Failure | 8 | 2020 | 1179 | 1.290 |
Why?
|
| Aorta, Thoracic | 3 | 2020 | 211 | 1.290 |
Why?
|
| Cardiovascular Surgical Procedures | 2 | 2019 | 36 | 1.230 |
Why?
|
| Aneurysm, False | 3 | 2018 | 60 | 1.220 |
Why?
|
| Pulmonary Veins | 2 | 2020 | 56 | 1.210 |
Why?
|
| Arteriovenous Malformations | 2 | 2020 | 34 | 1.200 |
Why?
|
| Clinical Decision-Making | 3 | 2017 | 109 | 1.190 |
Why?
|
| Truncus Arteriosus, Persistent | 2 | 2020 | 17 | 1.190 |
Why?
|
| Humans | 79 | 2023 | 68525 | 1.110 |
Why?
|
| Heart Valve Prosthesis Implantation | 5 | 2023 | 164 | 1.100 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2019 | 45 | 1.040 |
Why?
|
| Child | 19 | 2023 | 6400 | 0.970 |
Why?
|
| Heart Valve Prosthesis | 5 | 2021 | 222 | 0.970 |
Why?
|
| Heart Ventricles | 6 | 2020 | 738 | 0.950 |
Why?
|
| Subclavian Artery | 2 | 2020 | 30 | 0.870 |
Why?
|
| Aorta | 3 | 2019 | 316 | 0.840 |
Why?
|
| Cardiopulmonary Bypass | 9 | 2021 | 250 | 0.840 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2021 | 16 | 0.840 |
Why?
|
| Stenosis, Pulmonary Artery | 1 | 2021 | 3 | 0.840 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2022 | 47 | 0.830 |
Why?
|
| Pentalogy of Cantrell | 1 | 2021 | 1 | 0.830 |
Why?
|
| Abdominal Wall | 1 | 2021 | 20 | 0.810 |
Why?
|
| Surgical Flaps | 2 | 2020 | 120 | 0.810 |
Why?
|
| Diverticulum | 1 | 2021 | 29 | 0.800 |
Why?
|
| Aortic Diseases | 1 | 2022 | 113 | 0.780 |
Why?
|
| Pericardium | 3 | 2021 | 97 | 0.770 |
Why?
|
| Trisomy 18 Syndrome | 2 | 2020 | 6 | 0.770 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2020 | 15 | 0.750 |
Why?
|
| Professional Autonomy | 2 | 2017 | 24 | 0.730 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2019 | 25 | 0.710 |
Why?
|
| Treatment Outcome | 21 | 2023 | 7028 | 0.700 |
Why?
|
| Catheterization, Central Venous | 1 | 2020 | 89 | 0.700 |
Why?
|
| Coronary Aneurysm | 1 | 2019 | 19 | 0.690 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 20 | 0.690 |
Why?
|
| Infant, Newborn | 17 | 2023 | 2453 | 0.690 |
Why?
|
| Angina, Unstable | 1 | 2019 | 50 | 0.680 |
Why?
|
| Retrospective Studies | 23 | 2022 | 7264 | 0.680 |
Why?
|
| Male | 39 | 2021 | 37281 | 0.670 |
Why?
|
| Informed Consent | 2 | 2017 | 127 | 0.670 |
Why?
|
| Blalock-Taussig Procedure | 1 | 2018 | 20 | 0.650 |
Why?
|
| Angioplasty | 1 | 2019 | 118 | 0.640 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2017 | 6 | 0.620 |
Why?
|
| Ventricular Function, Left | 2 | 2017 | 481 | 0.610 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2013 | 117 | 0.610 |
Why?
|
| Heart Diseases | 4 | 2014 | 276 | 0.600 |
Why?
|
| Heart Septal Defects, Atrial | 3 | 2006 | 37 | 0.590 |
Why?
|
| Ventricular Function, Right | 1 | 2017 | 103 | 0.590 |
Why?
|
| Coronary Stenosis | 1 | 2019 | 246 | 0.580 |
Why?
|
| Ductus Arteriosus | 1 | 2016 | 13 | 0.570 |
Why?
|
| Down Syndrome | 1 | 2017 | 119 | 0.560 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2017 | 134 | 0.550 |
Why?
|
| Myxoma | 1 | 2015 | 17 | 0.550 |
Why?
|
| Child, Preschool | 12 | 2023 | 3185 | 0.540 |
Why?
|
| Heart Neoplasms | 1 | 2015 | 33 | 0.540 |
Why?
|
| Brachiocephalic Veins | 1 | 2015 | 9 | 0.530 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2019 | 2323 | 0.530 |
Why?
|
| Ventricular Outflow Obstruction | 2 | 2017 | 36 | 0.530 |
Why?
|
| Mitral Valve | 2 | 2019 | 166 | 0.520 |
Why?
|
| Endothelial Cells | 2 | 2020 | 384 | 0.520 |
Why?
|
| Aneurysm, Infected | 1 | 2014 | 16 | 0.510 |
Why?
|
| Streptococcal Infections | 1 | 2014 | 53 | 0.500 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2012 | 182 | 0.500 |
Why?
|
| Aortic Aneurysm | 1 | 2014 | 77 | 0.490 |
Why?
|
| Arteriovenous Fistula | 1 | 2014 | 25 | 0.490 |
Why?
|
| Hemodynamics | 9 | 2022 | 705 | 0.480 |
Why?
|
| Thrombosis | 1 | 2015 | 218 | 0.470 |
Why?
|
| Female | 32 | 2021 | 38015 | 0.470 |
Why?
|
| Centrifugation | 1 | 2013 | 16 | 0.470 |
Why?
|
| Cardiac Catheterization | 4 | 2017 | 419 | 0.460 |
Why?
|
| Preoperative Care | 3 | 2017 | 275 | 0.460 |
Why?
|
| Extracorporeal Circulation | 1 | 2013 | 26 | 0.460 |
Why?
|
| Echocardiography | 5 | 2019 | 515 | 0.460 |
Why?
|
| Magnetics | 1 | 2013 | 52 | 0.450 |
Why?
|
| Quality of Life | 2 | 2020 | 1515 | 0.450 |
Why?
|
| Stents | 2 | 2020 | 657 | 0.430 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2012 | 3 | 0.430 |
Why?
|
| Abnormalities, Multiple | 1 | 2012 | 109 | 0.420 |
Why?
|
| Ethics, Medical | 1 | 2012 | 86 | 0.410 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 371 | 0.400 |
Why?
|
| Thoracic Surgery | 1 | 2012 | 72 | 0.390 |
Why?
|
| Prosthesis Design | 4 | 2017 | 301 | 0.380 |
Why?
|
| Jugular Veins | 1 | 2010 | 37 | 0.380 |
Why?
|
| Pulmonary Valve | 2 | 2023 | 40 | 0.370 |
Why?
|
| Graft Rejection | 3 | 2021 | 458 | 0.370 |
Why?
|
| Aortic Valve | 5 | 2023 | 249 | 0.370 |
Why?
|
| Suture Techniques | 3 | 2012 | 75 | 0.360 |
Why?
|
| Adolescent | 11 | 2023 | 8903 | 0.350 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2021 | 50 | 0.350 |
Why?
|
| Bioprosthesis | 2 | 2021 | 101 | 0.340 |
Why?
|
| Follow-Up Studies | 5 | 2022 | 3256 | 0.340 |
Why?
|
| Rupture | 1 | 2008 | 29 | 0.330 |
Why?
|
| Tissue and Organ Procurement | 3 | 2021 | 164 | 0.330 |
Why?
|
| Physicians | 1 | 2012 | 324 | 0.320 |
Why?
|
| Forecasting | 2 | 2021 | 277 | 0.320 |
Why?
|
| Length of Stay | 6 | 2019 | 780 | 0.320 |
Why?
|
| Risk Assessment | 7 | 2022 | 2004 | 0.300 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2017 | 38 | 0.290 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2019 | 333 | 0.280 |
Why?
|
| Time Factors | 8 | 2019 | 4655 | 0.280 |
Why?
|
| Angiography | 2 | 2017 | 194 | 0.280 |
Why?
|
| Immunosuppressive Agents | 2 | 2022 | 514 | 0.280 |
Why?
|
| Elective Surgical Procedures | 2 | 2003 | 95 | 0.260 |
Why?
|
| Embolism, Paradoxical | 1 | 2005 | 6 | 0.260 |
Why?
|
| Models, Cardiovascular | 3 | 2022 | 133 | 0.260 |
Why?
|
| Conflict of Interest | 2 | 2017 | 48 | 0.250 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 2006 | 20 | 0.250 |
Why?
|
| Transplantation, Heterologous | 2 | 2021 | 122 | 0.250 |
Why?
|
| Hospital Mortality | 3 | 2016 | 384 | 0.240 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2003 | 9 | 0.230 |
Why?
|
| Hypercapnia | 1 | 2003 | 17 | 0.230 |
Why?
|
| Heart Valves | 2 | 2023 | 171 | 0.230 |
Why?
|
| Aortography | 2 | 2014 | 72 | 0.230 |
Why?
|
| Decision Support Techniques | 2 | 2016 | 191 | 0.230 |
Why?
|
| Coronary Artery Bypass | 2 | 2002 | 218 | 0.230 |
Why?
|
| Graft Survival | 2 | 2017 | 465 | 0.230 |
Why?
|
| Gastric Mucosa | 1 | 2003 | 77 | 0.220 |
Why?
|
| Colectomy | 1 | 2003 | 64 | 0.220 |
Why?
|
| Methylprednisolone | 2 | 2021 | 99 | 0.220 |
Why?
|
| Pulmonary Embolism | 1 | 2005 | 253 | 0.210 |
Why?
|
| Immune Privilege | 1 | 2021 | 2 | 0.210 |
Why?
|
| Rodentia | 1 | 2021 | 27 | 0.210 |
Why?
|
| Tricuspid Valve | 2 | 2019 | 42 | 0.210 |
Why?
|
| Ligation | 3 | 2017 | 83 | 0.200 |
Why?
|
| Swine | 3 | 2022 | 672 | 0.200 |
Why?
|
| Organ Transplantation | 1 | 2022 | 110 | 0.200 |
Why?
|
| Trisomy 13 Syndrome | 1 | 2020 | 5 | 0.190 |
Why?
|
| Adult | 12 | 2023 | 21375 | 0.190 |
Why?
|
| Risk Factors | 6 | 2017 | 5719 | 0.190 |
Why?
|
| Decision Making | 2 | 2016 | 410 | 0.190 |
Why?
|
| Biological Evolution | 1 | 2021 | 86 | 0.190 |
Why?
|
| Myocardial Ischemia | 2 | 2017 | 172 | 0.190 |
Why?
|
| Colonic Neoplasms | 1 | 2003 | 299 | 0.190 |
Why?
|
| Hepatic Veins | 1 | 2020 | 13 | 0.190 |
Why?
|
| Equipment Design | 3 | 2020 | 500 | 0.180 |
Why?
|
| Catheters, Indwelling | 1 | 2020 | 72 | 0.180 |
Why?
|
| Weaning | 1 | 2019 | 12 | 0.180 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2020 | 90 | 0.180 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2020 | 137 | 0.180 |
Why?
|
| Cohort Studies | 3 | 2021 | 2356 | 0.170 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2020 | 106 | 0.170 |
Why?
|
| Transplantation, Autologous | 1 | 2019 | 145 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 2 | 2020 | 503 | 0.170 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2019 | 92 | 0.170 |
Why?
|
| Polymers | 1 | 2020 | 244 | 0.170 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 536 | 0.170 |
Why?
|
| Child Development | 1 | 2019 | 102 | 0.160 |
Why?
|
| Siblings | 1 | 2018 | 34 | 0.160 |
Why?
|
| Aneurysm | 1 | 2018 | 53 | 0.160 |
Why?
|
| Animals | 7 | 2022 | 20877 | 0.160 |
Why?
|
| Ventricular Dysfunction | 1 | 2017 | 15 | 0.160 |
Why?
|
| Brain Injuries | 1 | 2021 | 268 | 0.160 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2017 | 24 | 0.150 |
Why?
|
| Induction Chemotherapy | 1 | 2017 | 39 | 0.150 |
Why?
|
| Vasoconstrictor Agents | 1 | 2017 | 107 | 0.150 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2017 | 37 | 0.140 |
Why?
|
| Milrinone | 1 | 2016 | 12 | 0.140 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2006 | 100 | 0.140 |
Why?
|
| Trisomy | 1 | 2016 | 47 | 0.140 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2017 | 123 | 0.140 |
Why?
|
| Cross-Sectional Studies | 2 | 2013 | 2264 | 0.140 |
Why?
|
| Myocardial Contraction | 1 | 2017 | 383 | 0.140 |
Why?
|
| Heart | 1 | 2020 | 850 | 0.140 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 138 | 0.130 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 791 | 0.130 |
Why?
|
| Enteral Nutrition | 1 | 2017 | 157 | 0.130 |
Why?
|
| Aged | 7 | 2008 | 14842 | 0.130 |
Why?
|
| Lung | 1 | 2020 | 849 | 0.130 |
Why?
|
| Streptococcus mitis | 1 | 2014 | 2 | 0.130 |
Why?
|
| Infant, Premature | 1 | 2017 | 284 | 0.130 |
Why?
|
| Odds Ratio | 2 | 2016 | 880 | 0.130 |
Why?
|
| Microarray Analysis | 1 | 2014 | 63 | 0.130 |
Why?
|
| HLA-C Antigens | 1 | 2014 | 8 | 0.130 |
Why?
|
| HLA-DQ Antigens | 1 | 2014 | 19 | 0.130 |
Why?
|
| Intensive Care Units | 3 | 2003 | 344 | 0.130 |
Why?
|
| Chromosome Aberrations | 1 | 2014 | 86 | 0.130 |
Why?
|
| Survival | 1 | 2014 | 22 | 0.120 |
Why?
|
| Histocompatibility Testing | 1 | 2014 | 38 | 0.120 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2014 | 11 | 0.120 |
Why?
|
| Heart Bypass, Right | 1 | 2014 | 30 | 0.120 |
Why?
|
| Acute Disease | 2 | 2019 | 658 | 0.120 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 1046 | 0.120 |
Why?
|
| Counseling | 1 | 2016 | 279 | 0.120 |
Why?
|
| Pulmonary Circulation | 1 | 2014 | 79 | 0.120 |
Why?
|
| Disease Progression | 1 | 2017 | 1037 | 0.120 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2013 | 33 | 0.120 |
Why?
|
| Septal Occluder Device | 1 | 2013 | 21 | 0.120 |
Why?
|
| Sternotomy | 1 | 2013 | 18 | 0.120 |
Why?
|
| Histocompatibility | 1 | 2013 | 17 | 0.120 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2013 | 3 | 0.120 |
Why?
|
| Coronary Angiography | 1 | 2019 | 866 | 0.120 |
Why?
|
| Ultrasonography | 1 | 2015 | 453 | 0.120 |
Why?
|
| Anastomosis, Surgical | 1 | 2013 | 104 | 0.120 |
Why?
|
| Heart Injuries | 1 | 2013 | 25 | 0.110 |
Why?
|
| Multiple Trauma | 1 | 2013 | 50 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 938 | 0.110 |
Why?
|
| Equipment Failure Analysis | 1 | 2013 | 121 | 0.110 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2014 | 186 | 0.110 |
Why?
|
| Heart Septal Defects | 1 | 2012 | 27 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 503 | 0.110 |
Why?
|
| Prosthesis Implantation | 1 | 2013 | 83 | 0.110 |
Why?
|
| Predictive Value of Tests | 4 | 2019 | 1465 | 0.110 |
Why?
|
| Middle Aged | 8 | 2021 | 21119 | 0.110 |
Why?
|
| Renal Dialysis | 1 | 2013 | 174 | 0.110 |
Why?
|
| Negotiating | 1 | 2012 | 18 | 0.110 |
Why?
|
| Transplantation, Homologous | 2 | 2023 | 242 | 0.110 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 121 | 0.110 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2013 | 131 | 0.110 |
Why?
|
| United Kingdom | 1 | 2012 | 152 | 0.100 |
Why?
|
| Intraoperative Period | 3 | 2019 | 62 | 0.100 |
Why?
|
| Aprotinin | 1 | 2011 | 55 | 0.100 |
Why?
|
| Hemostatics | 1 | 2011 | 47 | 0.100 |
Why?
|
| Postoperative Hemorrhage | 1 | 2011 | 69 | 0.100 |
Why?
|
| Blood Loss, Surgical | 1 | 2011 | 79 | 0.100 |
Why?
|
| Incidence | 3 | 2019 | 1582 | 0.100 |
Why?
|
| Phenotype | 1 | 2013 | 946 | 0.090 |
Why?
|
| Young Adult | 3 | 2021 | 5708 | 0.090 |
Why?
|
| Pediatrics | 1 | 2013 | 341 | 0.090 |
Why?
|
| Cattle | 1 | 2010 | 475 | 0.090 |
Why?
|
| Biomarkers | 3 | 2021 | 1593 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 1139 | 0.090 |
Why?
|
| Age Factors | 3 | 2019 | 1860 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 1026 | 0.080 |
Why?
|
| Liver | 1 | 2013 | 1118 | 0.080 |
Why?
|
| United States | 4 | 2021 | 7335 | 0.070 |
Why?
|
| Survival Rate | 3 | 2021 | 1055 | 0.070 |
Why?
|
| South Carolina | 1 | 2013 | 2750 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2023 | 3702 | 0.070 |
Why?
|
| Multiple Organ Failure | 2 | 2006 | 36 | 0.070 |
Why?
|
| Regression Analysis | 2 | 2014 | 737 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 2550 | 0.070 |
Why?
|
| Gestational Age | 2 | 2017 | 389 | 0.070 |
Why?
|
| Protein S Deficiency | 1 | 2005 | 4 | 0.070 |
Why?
|
| Prognosis | 2 | 2021 | 2093 | 0.060 |
Why?
|
| Vena Cava Filters | 1 | 2005 | 18 | 0.060 |
Why?
|
| Warfarin | 1 | 2005 | 93 | 0.060 |
Why?
|
| Leg | 1 | 2005 | 191 | 0.060 |
Why?
|
| Venous Thrombosis | 1 | 2005 | 124 | 0.060 |
Why?
|
| Logistic Models | 2 | 2017 | 1419 | 0.050 |
Why?
|
| Mycophenolic Acid | 1 | 2022 | 62 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2003 | 100 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2005 | 356 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 1745 | 0.050 |
Why?
|
| Transplantation, Heterotopic | 1 | 2021 | 7 | 0.050 |
Why?
|
| Manometry | 1 | 2003 | 276 | 0.050 |
Why?
|
| Tissue Adhesions | 1 | 2021 | 21 | 0.050 |
Why?
|
| Calcium Chloride | 1 | 2021 | 38 | 0.050 |
Why?
|
| Risk | 1 | 2003 | 563 | 0.050 |
Why?
|
| Polytetrafluoroethylene | 1 | 2021 | 55 | 0.050 |
Why?
|
| Tacrolimus | 1 | 2022 | 127 | 0.050 |
Why?
|
| Patient Selection | 2 | 2016 | 592 | 0.050 |
Why?
|
| Waiting Lists | 1 | 2021 | 104 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2021 | 238 | 0.050 |
Why?
|
| Myocardial Revascularization | 1 | 2001 | 56 | 0.050 |
Why?
|
| Regeneration | 1 | 2021 | 105 | 0.050 |
Why?
|
| Blood Transfusion | 1 | 2002 | 205 | 0.050 |
Why?
|
| Models, Animal | 1 | 2021 | 252 | 0.050 |
Why?
|
| Cardiomyopathies | 1 | 2002 | 167 | 0.050 |
Why?
|
| Heart Valve Diseases | 1 | 2020 | 123 | 0.040 |
Why?
|
| Health Policy | 1 | 2021 | 221 | 0.040 |
Why?
|
| Materials Testing | 1 | 2020 | 263 | 0.040 |
Why?
|
| Critical Care | 1 | 2002 | 263 | 0.040 |
Why?
|
| Ischemic Attack, Transient | 1 | 2001 | 167 | 0.040 |
Why?
|
| Reoperation | 2 | 2017 | 467 | 0.040 |
Why?
|
| Child Language | 1 | 2019 | 5 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2019 | 215 | 0.040 |
Why?
|
| Infant Behavior | 1 | 2019 | 12 | 0.040 |
Why?
|
| Pedigree | 1 | 2018 | 159 | 0.040 |
Why?
|
| Operating Rooms | 1 | 1999 | 108 | 0.040 |
Why?
|
| Primary Graft Dysfunction | 1 | 2017 | 12 | 0.040 |
Why?
|
| Trauma Centers | 1 | 1999 | 197 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2019 | 222 | 0.040 |
Why?
|
| Ventricular Function | 1 | 2017 | 93 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 1851 | 0.040 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2017 | 101 | 0.040 |
Why?
|
| Propensity Score | 1 | 2017 | 116 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2021 | 1173 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2019 | 682 | 0.040 |
Why?
|
| Infant, Extremely Premature | 1 | 2016 | 18 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 567 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 306 | 0.030 |
Why?
|
| Birth Weight | 1 | 2016 | 186 | 0.030 |
Why?
|
| Motor Activity | 1 | 2019 | 621 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2019 | 1737 | 0.030 |
Why?
|
| Infant, Premature, Diseases | 1 | 2016 | 85 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 546 | 0.030 |
Why?
|
| Cognition | 1 | 2019 | 512 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 929 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 621 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 652 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2014 | 168 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 506 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2014 | 159 | 0.030 |
Why?
|
| Transplant Recipients | 1 | 2014 | 109 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 5300 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2014 | 195 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 848 | 0.030 |
Why?
|
| Palliative Care | 1 | 2014 | 271 | 0.030 |
Why?
|
| Intermittent Claudication | 1 | 2011 | 31 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2011 | 113 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2077 | 0.020 |
Why?
|
| Radiography | 1 | 2011 | 572 | 0.020 |
Why?
|
| Stroke | 1 | 2001 | 2161 | 0.020 |
Why?
|
| Warm Ischemia | 1 | 2006 | 8 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2006 | 164 | 0.020 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2006 | 174 | 0.020 |
Why?
|
| Hospital Charges | 1 | 2002 | 60 | 0.010 |
Why?
|
| Hypertension | 1 | 2011 | 1531 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2002 | 193 | 0.010 |
Why?
|
| Cause of Death | 1 | 2002 | 241 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2002 | 319 | 0.010 |
Why?
|
| Tracheostomy | 1 | 1999 | 31 | 0.010 |
Why?
|
| Laparotomy | 1 | 1999 | 65 | 0.010 |
Why?
|
| Gastrostomy | 1 | 1999 | 110 | 0.010 |
Why?
|
| Critical Illness | 1 | 1999 | 191 | 0.010 |
Why?
|